litlas
Log inCreate account

Thomas M. Kündig

Active 1991–2025

99
Papers
19,598
Citations
70
h-index
97
i10-index

Citations

Citations per year for Thomas M. Kündig1991: 6 citations1992: 27 citations1993: 55 citations1994: 130 citations1995: 212 citations1996: 218 citations1997: 278 citations1998: 315 citations1999: 316 citations2000: 332 citations2001: 259 citations2002: 248 citations2003: 186 citations2004: 210 citations2005: 175 citations2006: 163 citations2007: 149 citations2008: 167 citations2009: 148 citations2010: 126 citations2011: 142 citations2012: 154 citations2013: 151 citations2014: 134 citations2015: 133 citations2016: 120 citations2017: 151 citations2018: 136 citations2019: 361 citations2020: 517 citations2021: 406 citations2022: 307 citations2023: 257 citations2024: 372 citations2025: 201 citations2026: 4 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,949 citing papers, 33% of this breakdownGermany: 696 citing papers, 7.8% of this breakdownUnited Kingdom: 556 citing papers, 6.2% of this breakdownSwitzerland: 508 citing papers, 5.7% of this breakdownChina: 476 citing papers, 5.3% of this breakdownCanada: 379 citing papers, 4.2% of this breakdownJapan: 358 citing papers, 4% of this breakdownFrance: 353 citing papers, 4% of this breakdownAustralia: 276 citing papers, 3.1% of this breakdownItaly: 247 citing papers, 2.8% of this breakdownNetherlands: 174 citing papers, 2% of this breakdownSpain: 164 citing papers, 1.8% of this breakdown
0%33%Other 20.1%

Institutions

Fields

  • Immunology and Microbiology45.6%
  • Medicine29.2%
  • Biochemistry, Genetics and Molecular Biology16.5%
  • Neuroscience4.1%
  • Pharmacology, Toxicology and Pharmaceutics1%
  • Agricultural and Biological Sciences0.8%
  • Other2.8%

Topics

  • Immune Cell Function and Interaction10.4%
  • T-cell and B-cell Immunology9.9%
  • Immunotherapy and Immune Responses9.3%
  • Immune Response and Inflammation4.6%
  • Allergic Rhinitis and Sensitization1.9%
  • Cytokine Signaling Pathways and Interactions1.8%
  • Other62.1%

Coauthors

All papers

Open in search
  1. Inflammation in acute myocardial infarction: the good, the bad and the ugly

    Authors: M. Matter, Francesco Paneni, Peter Libby, Stefan Frantz, Barbara E. Stähli, Christian Templin, Alessandro Mengozzi, Yu-Jen Wang, Thomas M. Kündig, Lorenz Räber, Frank Ruschitzka, Christian M. Matter - European Heart Journal 2023 cited by 312

  2. Stroma-Derived Interleukin-34 Controls the Development and Maintenance of Langerhans Cells and the Maintenance of Microglia

    Authors: Melanie Greter, Iva Lelios, Paweł Pelczar, Guillaume Hoeffel, Jeremy Price, Marylène Leboeuf, Thomas M. Kündig, Karl Frei, Florent Ginhoux, Miriam Mérad, Burkhard Becher - Immunity 2012 cited by 605

  3. The Influence of Antigen Organization on B Cell Responsiveness

    Authors: Martin F. Bachmann, Urs Hoffmann Rohrer, Thomas M. Kündig, Kurt Bürki, Hans Hengartner, Rolf M. Zinkernagel - Science 1993 cited by 733

  4. Protamine-Based Strategies for RNA Transfection

    Authors: Natalia Teresa Jarzębska, Mark Mellett, Julia Frei, Thomas M. Kündig, Steve Pascolo - Pharmaceutics 2021 cited by 91

  5. Oxidative stress and altered mitochondrial protein expression in the absence of amyloid-β and tau pathology in iPSC-derived neurons from sporadic Alzheimer's disease patients

    Authors: Julian H. Birnbaum, Debora Wanner, Anton Gietl, Antje Saake, Thomas M. Kündig, Christoph Höck, Roger M. Nitsch, Christian Tackenberg - Stem Cell Research 2018 cited by 140

  6. Antigen kinetics determines immune reactivity

    Authors: Pål Johansen, Tazio Storni, Lorna Rettig, Zhiyong Qiu, Ani Der-Sarkissian, Kent A. Smith, Vania Manolova, Karl S. Lang, Gabriela Senti, Beat Müllhaupt, Tilman Gerlach, Roberto F. Speck, Adrian Bot, Thomas M. Kündig - National Academy of Sciences, Proceedings of the National Academy of Sciences 2008 cited by 187

  7. Design of in vitro Transcribed mRNA Vectors for Research and Therapy

    Authors: Marina Tusup, Lars E. French, Mara De Matos, David Gatfield, Thomas M. Kündig, Steve Pascolo - CHIMIA International Journal for Chemistry 2019 cited by 54

  8. Virus-induced humoral immunity: on how B cell responses are initiated

    Authors: Franziska Zabel, Thomas M. Kündig, Martin F. Bachmann - Current Opinion in Virology 2013 cited by 112

  9. Targeting Mutated Plus Germline Epitopes Confers Pre-clinical Efficacy of an Instantly Formulated Cancer Nano-Vaccine

    Authors: Mona O. Mohsen, Monique Vogel, Carsten Riether, Julius Müller, Silvia Salatino, Nicola Ternette, Ariane C. Gomes, Gustavo Cabral‐Miranda, Aadil El-Turabi, Christiane Ruedl, Thomas M. Kündig, Said Dermime, Alexander Knuth, Daniel E. Speiser, Martin F. Bachmann - Frontiers in Immunology 2019 cited by 56

  10. Vaccine against peanut allergy based on engineered virus-like particles displaying single major peanut allergens

    Authors: Federico Storni, Andris Zeltiņš, Ina Baļķe, Matthew D. Heath, Matthias Krämer, Murray Skinner, Lisha Zha, Elisa S. Roesti, Paul Engeroff, Lukas Muri, Diego von Werdt, Thomas Gruber, Mark S. Cragg, Małgorzata Młynarczyk, Thomas M. Kündig, Monique Vogel, Martin F. Bachmann - Journal of Allergy and Clinical Immunology 2019 cited by 105

  11. Vaccination with nanoparticles combined with micro-adjuvants protects against cancer

    Authors: Mona O. Mohsen, Matthew D. Heath, Gustavo Cabral‐Miranda, Cyrill Lipp, Andris Zeltiņš, Marcos Sande-Melón, Jens V. Stein, Carsten Riether, Elisa S. Roesti, Lisha Zha, Paul Engeroff, Aadil El-Turabi, Thomas M. Kündig, Monique Vogel, Murray Skinner, Daniel E. Speiser, Alexander Knuth, Matthias Krämer, Martin F. Bachmann - Journal for ImmunoTherapy of Cancer 2019 cited by 59

  12. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection

    Authors: Klaus Pfeffer, T. Matsuyama, Thomas M. Kündig, Andrew Wakeham, Kenji Kishihara, Arda Shahinian, Katja Wiegmann, Pamela S. Ohashi, Martin Krönke, Tak W. Mak - Cell 1993 cited by 1,707

  13. IL-12 protects from psoriasiform skin inflammation

    Authors: Paulina Kulig, Stephanie Musiol, Sandra N. Freiberger, Bettina Schreiner, Gábor Gyülvészi, Giancarlo Russo, Stanislav Pantelyushin, Kenji Kishihara, Francesca Alessandrini, Thomas M. Kündig, Federica Sallusto, Günther F.L. Hofbauer, Stefan Haak, Burkhard Becher - Nature Communications 2016 cited by 193

  14. Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development

    Authors: T. Matsuyama, Tohru Kimura, Motoo Kitagawa, Klaus Pfeffer, Takatoshi Kawakami, Nobumasa Watanabe, Thomas M. Kündig, Ryuichi Amakawa, Kenji Kishihara, Andrew Wakeham, Julia M. Potter, Caren Furlonger, A. Narendran, Haruhiko Suzuki, Pamela S. Ohashi, Christopher J. Paige, Tadatsugu Taniguchi, Tak W. Mak - Cell 1993 cited by 645

  15. A scalable and highly immunogenic virus‐like particle‐based vaccine against SARS‐CoV‐2

    Authors: Mona O. Mohsen, Ina Baļķe, Simon Zinkhan, Villija Zeltina, Xuelan Liu, Xinyue Chang, Pascal S. Krenger, Kevin Plattner, Zahra Gharailoo, Anne‐Cathrine S. Vogt, Gilles Augusto, Marianne Zwicker, Salony Roongta, Dominik A. Rothen, Romano Josi, Joana J. da Costa, Jan M. Sobczak, Aleksandra Nonic, Lee‐Anne Brand, Katja Nuss, B Martina, Daniel E. Speiser, Thomas M. Kündig, Gary T. Jennings, Senta M. Walton, Monique Vogel, Andris Zeltiņš, Martin F. Bachmann - Allergy 2021 cited by 57

  16. Deregulated T Cell Activation and Autoimmunity in Mice Lacking Interleukin-2 Receptor β

    Authors: Haruhiko Suzuki, Thomas M. Kündig, Caren Furlonger, Andrew Wakeham, Emma Timms, T. Matsuyama, Rudolf Schmits, John Simard, Pamela S. Ohashi, Henrik Griesser, Tadatsugu Taniguchi, Christopher J. Paige, Tak W. Mak - Science 1995 cited by 861

  17. Requirement for the Transcription Factor LSIRF/IRF4 for Mature B and T Lymphocyte Function

    Authors: Hans‐Willi Mittrücker, T. Matsuyama, Alex Grossman, Thomas M. Kündig, Julia M. Potter, Arda Shahinian, Andrew Wakeham, Bruce Patterson, Pamela S. Ohashi, Tak W. Mak - Science 1997 cited by 596

  18. Intralymphatic allergen administration renders specific immunotherapy faster and safer: A randomized controlled trial

    Authors: Gabriela Senti, Bettina M. Prinz Vavricka, Iris Erdmann, Mella I. Diaz, Richárd Márkus, Stephen J. McCormack, John Simard, Brunello Wüthrich, Reto Crameri, Nicole Graf, Pål Johansen, Thomas M. Kündig - National Academy of Sciences, Proceedings of the National Academy of Sciences 2008 cited by 364

  19. PTPN2 Regulates Inflammasome Activation and Controls Onset of Intestinal Inflammation and Colon Cancer

    Authors: Marianne R. Spalinger, Roberto Manzini, Larissa Hering, Julianne B. Riggs, Claudia Gottier, Silvia Lang, Kirstin Atrott, Antonia Fettelschoss‐Gabriel, Florian Olomski, Thomas M. Kündig, Michael Fried, Declan F. McCole, Gerhard Rogler, Michael Scharl - Cell Reports 2018 cited by 100

  20. The next generation virus‐like particle platform for the treatment of peanut allergy

    Authors: Jan M. Sobczak, Pascal S. Krenger, Federico Storni, Mona O. Mohsen, Ina Baļķe, Gunta Resēviča, Matthew D. Heath, Thalia L. Carreno Velazquez, Matthias Krämer, Callum J. W. Scott, Murray Skinner, Andris Zeltiņš, Thomas M. Kündig, Monique Vogel, Martin F. Bachmann - Allergy 2023 cited by 31

  21. Immunization of cats to induce neutralizing antibodies against Fel d 1, the major feline allergen in human subjects

    Authors: Franziska Thoms, Gary T. Jennings, Melanie Maudrich, Monique Vogel, Stefanie Haas, Andris Zeltiņš, Regina Hofmann‐Lehmann, Barbara Riond, Jonas Grossmann, Peter Hunziker, Antonia Fettelschoss‐Gabriel, Gabriela Senti, Thomas M. Kündig, Martin F. Bachmann - Journal of Allergy and Clinical Immunology 2019 cited by 67

  22. CD8 is needed for development of cytotoxic T but not helper T cells

    Authors: Wai‐Ping Fung‐Leung, Marco W. Schilham, Amin Rahemtulla, Thomas M. Kündig, Maja Vollenweider, Julia M. Potter, Willem van Ewijk, Tak W. Mak - Cell 1991 cited by 526

  23. Use of A‐type CpG oligodeoxynucleotides as an adjuvant in allergen‐specific immunotherapy in humans: a phase I/IIa clinical trial

    Authors: Gabriela Senti, Pål Johansen, Finn‐Mogens Šmejda Haug, Carroll G. Bull, C. Gottschaller, P Müller, Th. Pfister, Patrik Maurer, Martin F. Bachmann, Norbert Graf, Thomas M. Kündig - Clinical & Experimental Allergy 2009 cited by 218

  24. Direct intralymphatic injection of peptide vaccines enhances immunogenicity

    Authors: Pål Johansen, Andreas C. Häffner, Frauke K. Koch, Karoline Zepter, Iris Erdmann, Kevin J. Maloy, John Simard, Tazio Storni, Gabriela Senti, Adrian Bot, B. Wüthrich, Thomas M. Kündig - European Journal of Immunology 2005 cited by 125